迈普医学
(301033)
| 流通市值：31.86亿 | | | 总市值：37.86亿 |
| 流通股本：5597.76万 | | | 总股本：6651.94万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 38,367,077.66 | 57,454,182.63 | 41,795,654.28 | 32,033,529.88 |
| 应收票据及应收账款 | 23,805,472.59 | 24,163,125.29 | 11,596,244.33 | 13,895,171.13 |
| 应收账款 | 23,805,472.59 | 24,163,125.29 | 11,596,244.33 | 13,895,171.13 |
| 预付款项 | 5,102,279.78 | 2,905,830.09 | 2,949,629.52 | 3,424,741.2 |
| 其他应收款合计 | 1,497,895.8 | 1,194,147.12 | 1,662,386.01 | 1,581,678.23 |
| 存货 | 36,038,896.66 | 34,279,356.89 | 35,399,678.5 | 33,720,003.74 |
| 一年内到期的非流动资产 | 43,990,721.04 | 54,476,707.32 | 54,041,912.81 | 30,000,000 |
| 其他流动资产 | 189,894.69 | 83,354.36 | 121,998.31 | 260,469.61 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 300,948,007.36 | 312,406,407.83 | 285,882,172.38 | 227,575,931.84 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 2,335,271.84 | 2,274,674.01 | 2,349,757.17 | 2,266,278.53 |
| 其他非流动金融资产 | 88,000,000 | 58,000,000 | 28,000,000 | 28,000,000 |
| 投资性房地产 | 11,261,558.52 | 11,332,795.08 | 11,404,031.64 | 11,469,523.15 |
| 固定资产 | 304,290,956.79 | 308,640,573.8 | 310,511,680.01 | 313,350,363.07 |
| 在建工程 | 153,123.85 | - | 97,981.65 | - |
| 使用权资产 | 452,080.22 | 808,488.65 | 1,164,897.08 | 1,521,305.51 |
| 无形资产 | 73,616,584.97 | 63,054,946.59 | 64,800,853.56 | 66,516,320.28 |
| 开发支出 | 21,073,018.53 | 31,990,289.1 | 28,991,331.04 | 25,310,872.28 |
| 长期待摊费用 | 1,879,422.9 | 2,133,257.01 | 2,175,255.31 | 2,072,998.47 |
| 递延所得税资产 | 8,957,724.56 | 7,665,058.64 | 7,174,241.14 | 5,437,893.99 |
| 其他非流动资产 | 3,002,166.84 | 923,834.13 | 1,920,925.45 | 26,288,899.73 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 515,021,909.02 | 486,823,917.01 | 458,590,954.05 | 482,234,455.01 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 815,969,916.38 | 799,230,324.84 | 744,473,126.43 | 709,810,386.85 |
| 流动负债: | | | | |
| 衍生金融负债 | 60,284.16 | 23,149.21 | - | - |
| 应付票据及应付账款 | 10,965,023.5 | 7,589,695.7 | 9,452,397.61 | 10,186,092.6 |
| 应付账款 | 10,965,023.5 | 7,589,695.7 | 9,452,397.61 | 10,186,092.6 |
| 预收款项 | 3,900,419.4 | 5,320,589.91 | 6,080,622.86 | 4,720,150.3 |
| 合同负债 | 1,296,069.88 | 699,209.77 | 692,883.39 | 1,588,269.31 |
| 应付职工薪酬 | 6,145,825.32 | 15,443,121.53 | 5,316,940.32 | 4,680,146.78 |
| 应交税费 | 11,945,539.74 | 13,487,936.66 | 10,383,086.14 | 9,456,513.74 |
| 其他应付款合计 | 2,567,923.21 | 3,838,424.64 | 11,850,694.49 | 2,518,063.57 |
| 一年内到期的非流动负债 | 556,367.36 | 1,014,361.39 | 1,315,975.69 | 1,613,922.6 |
| 其他流动负债 | 41,522.74 | 59,793.5 | 28,854.15 | 44,582.86 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 37,478,975.31 | 47,476,282.31 | 45,121,454.65 | 34,807,741.76 |
| 非流动负债: | | | | |
| 租赁负债 | - | - | 150,868.55 | 299,959.63 |
| 递延收益 | 50,283,217.86 | 51,795,729.58 | 35,629,498.06 | 36,952,949.09 |
| 递延所得税负债 | 253,326.68 | 293,619.99 | 301,727.24 | 253,836.59 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 50,536,544.54 | 52,089,349.57 | 36,082,093.85 | 37,506,745.31 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 88,015,519.85 | 99,565,631.88 | 81,203,548.5 | 72,314,487.07 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 66,519,431 | 66,519,431 | 66,062,951 | 66,062,951 |
| 资本公积 | 468,021,996.12 | 463,945,604.74 | 453,995,026.11 | 448,703,908.48 |
| 减:库存股 | 11,509,159.15 | 11,509,159.15 | 11,509,159.15 | 11,509,159.15 |
| 其他综合收益 | 1,234,092.41 | 1,183,087.22 | 1,246,284.71 | 1,176,020.74 |
| 盈余公积 | 21,322,714.94 | 21,322,714.94 | 12,939,995.52 | 12,939,995.52 |
| 未分配利润 | 182,365,321.21 | 158,203,014.21 | 140,534,479.74 | 120,122,183.19 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 727,954,396.53 | 699,664,692.96 | 663,269,577.93 | 637,495,899.78 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 727,954,396.53 | 699,664,692.96 | 663,269,577.93 | 637,495,899.78 |
| 负债和股东权益合计 | 815,969,916.38 | 799,230,324.84 | 744,473,126.43 | 709,810,386.85 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-29 | 2024-08-17 |
| 审计意见(境内) | | 标准无保留意见 | | |